Cargando…

Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al

Detalles Bibliográficos
Autores principales:	Bakasis, Athanasios‐Dimitrios, Goules, Andreas V., Vlachoyiannopoulos, Panayiotis G., Bitzogli, Kleopatra, Tzioufas, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347727/ https://www.ncbi.nlm.nih.gov/pubmed/35588445 http://dx.doi.org/10.1002/acr2.11446

Ejemplares similares

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Tzioufas, Athanasios G., et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece
por: Vlachoyiannopoulos, Panayiotis, et al.
Publicado: (2020)

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020)

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023)

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies
por: Boutzios, Georgios, et al.
Publicado: (2022)

Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
por: Panagopoulos, Panagiotis, et al.
Publicado: (2021)

Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases
por: Argyropoulou, Ourania D., et al.
Publicado: (2021)

Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
por: Agryropoulou, Ourania, et al.
Publicado: (2018)

COVID-19 Immunobiology: Lessons Learned, New Questions Arise
por: Kaklamanos, Aimilios, et al.
Publicado: (2021)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
por: Panagopoulos, Panagiotis K., et al.
Publicado: (2022)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

DNA Methylation Studies in Saliva of Patients with Sjögren’s Syndrome
por: Karagianni, Panagiota, et al.
Publicado: (2021)

Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren’s Syndrome
por: Stergiou, Ioanna E., et al.
Publicado: (2022)

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
por: Kosmidis, Michalis L., et al.
Publicado: (2019)

Polonia XXX
Publicado: (1974)

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
por: Kampylafka, Eleni I., et al.
Publicado: (2013)

Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren’s Syndrome
por: Chatzis, Loukas, et al.
Publicado: (2021)

Volume XXX.—Alpha
Publicado: (1890)

Volume XXX.—Omega
Publicado: (1891)

A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data
por: Pezoulas, Vasileios C., et al.
Publicado: (2021)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Séminaire de probabilités XXX
por: Azéma, Jacques, et al.
Publicado: (1996)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

Epigenetic alterations in Sjögren’s syndrome patient saliva
por: Karagianni, P., et al.
Publicado: (2020)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Book Review: Rheumatology in Questions
por: Tzioufas, Athanasios G.
Publicado: (2020)

Hydroxychloroquine/mycophenolate mofetil/rituximab: Human coronavirus infection: case report
Publicado: (2022)

Geometric Methods in Physics : XXX Workshop
por: Kielanowski, Piotr, et al.
Publicado: (2013)

Solid state science and technology XXX
por: Suhaimi, Syahida, et al.
Publicado: (2020)

"The Hospital" Medical Book Supplement—No. XXX
Publicado: (1910)

Water Loss from Protonated XxxSer and XxxThr Dipeptides Gives Oxazoline—Not Oxazolone—Product Ions
por: Oomens, Jos, et al.
Publicado: (2020)

Sex chromosome aneuploidies and fertility: 47,XXY, 47,XYY, 47,XXX and 45,X/47,XXX
por: Rogol, Alan D
Publicado: (2023)

Cell‐Based Therapies: The Nonresponder
por: Caplan, Arnold I.
Publicado: (2018)

Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
por: Lionaki, Sophia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kjbbefg8alfji7e7g8gq7dmrtk